Flexion Therapeutics Inc (NASDAQ:FLXN)

27.49
Delayed Data
As of May 21
 -0.27 / -0.97%
Today’s Change
16.51
Today|||52-Week Range
32.25
+9.78%
Year-to-Date
No recent news for Flexion Therapeutics Inc.

Today’s Trading

Previous close27.76
Today’s open28.00
Day’s range27.28 - 28.00
Volume510,805
Average volume (3 months)716,288
Market cap$997.0M
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-46.48%
Earnings growth (this year)-16.29%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales2,329.57
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.23-2.16%
INSMInsmed Inc-2.14-7.52%
CYTKCytokinetics Inc-0.50-5.46%
AKAOAchaogen Inc-0.64-5.14%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$1.26
Annual revenue (last year)$355.0K
Annual profit (last year)-$137.5M
Net profit margin-38,727.04%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial &
Accounting Officer
David A. Arkowitz
Corporate headquarters
Burlington, Massachusetts

Forecasts